Right Turn: Blog Carnival five-year roundup

In 2016, I stumbled upon the concept of a “blog carnival” and I was excited to give it a whirl. It was so much fun and such a success that, five years later, it is now a regular summer feature on Signals. You can look forward to it in the same way that “Torontonians” look forward to the Canadian National Exhibition (CNE) – a giant fair with rides, games, entertainment, odd food and much more – that  happens every August in Toronto, Canada. But not this August. Which means that if we can keep going for another 138 years without interruption, we’ll beat the CNE’s impressive record.

Whether you are new to the blog carnival or you’ve been here before, I invite you to read any of the topics you have missed, as follows:

2016 – At the 10-year anniversary of the discovery that adult stem cells can be reprogrammed into induced Pluripotent Stem Cells, I asked when would this technology result in commercial products or new revolutionary medical treatments? Did our bloggers get it right five years ago?

2017 – This year we tackled the controversial Right-to-Try. Were our bloggers for or against it?

2018 – After decades of hard work, excitement for cell and gene therapies was palpable two years ago. Did that mean the industry had finally “arrived?” Our bloggers explored that question and reached different conclusions. How did they do?

2019 – Last year I asked the question “What are the hurdles in your country impacting patient access to cell and gene therapies?” For the answer, I invited experts from Canada, the U.S., the United Kingdom and Australia to comment. I wonder if any of their answers will surprise you.

2020 – This year, in the middle of a pandemic, I wanted our experts to comment on how COVID-19 will affect the cell and gene therapy industry – for good and for bad. If you missed it last week, catch up now.

Watch this video to feel like you’re at the CNE. It will also put you in a relaxing mood while reading the blogs.

The following two tabs change content below.

• Bio
• Latest Posts

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Latest posts by Stacey Johnson (see all)

• Right Turn: #pinksocks, diabetes news and other ramblings - June 24, 2025
• Right Turn: Some takeaways from Advanced Therapies Week 2025 - January 31, 2025
• Right Turn: The top 10 most-read blog posts in 2024 - January 2, 2025